SCHEMBL3559669

SCHEMBL3559669

CCCCCCCCC(=O)Nc1ccccc1OCCOc1ccc(C(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.59
TSHR P16473 1/20 0.59
PLA2G4B P0C869 6/20 0.57
POLB P06746 1/20 0.57
ATM Q13315 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
PLK1 P53350 1/20 0.56
RARB P10826 4/20 0.55
PLA2G4A P47712 1/20 0.53
SOAT1 P35610 2/20 0.52
GAA P10253 1/20 0.51
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3555944 1.00 TP53 (0.59) TP53TSHRPLA2G4BPOLBATM
SCHEMBL3553707 0.99 L3MBTL1 (0.58) TP53TSHRPLA2G4BPOLBATM
SCHEMBL3559044 0.95 POLB (0.62) TP53TSHRPLA2G4BPOLBATM
SCHEMBL3557542 0.91 GAA (0.56) TP53TSHRPLA2G4BPOLBATM
SCHEMBL11644679 0.88 GAA (0.64) TSHRPOLBATML3MBTL1SOAT1
SCHEMBL3557480 0.85 CYP2C19 (0.62) POLBL3MBTL1GAA
SCHEMBL8158170 0.83 CYP2C19 (0.64) POLBATML3MBTL1SOAT1GAA
SCHEMBL3555523 0.81 TSHR (0.56) TSHRL3MBTL1GAA
SCHEMBL3556661 0.81 L3MBTL1 (0.65) TSHRPOLBL3MBTL1
SCHEMBL3556618 0.81 POLB (0.62) TSHRPOLBL3MBTL1RARBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 TP53 3590/4885TSHR 3483/4885PLA2G4B 1242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.